Manufacturers must guard against production disruptions from other international dustups, says Moody’s Supply Chain Director Sapna Amlani.
Continue reading →
Manufacturers are the top target for cyberattacks in 2025 because of their still-plentiful cybersecurity gaps and a lack of expertise.
Continue reading →
Remember when Apple put that U2 album in everyone’s music libraries? India wanted to do that to all of its citizens, but with a cybersecurity app. It wasn’t a good idea.
Continue reading →
Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of bone disease. Obodence, referencing Amgen’s Prolia, has been approved for the treatment of osteoporosis in postmenopausal women and in men at increased risk of...
Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team. Otto has served at Vetter for over 35 years and has been heavily involved in shaping the company’s sustainable development and continued growth. He will step down at...
Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its treatment for chronic (CM) and episodic migraine (EM). AJOVY is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody administered as a subcutaneous injection. The PEARL study of AJOVY took...